ARCHIVES

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Bennett, Federal Prosecutors Reach $475,000 Settlement

October 31, 2014

NCI Nears Confrontation Over Construction As OMB Continues Obstructionist Policies

July 11, 1975

NCI Seeks to Maintain Grant Success Rate As Budget Deadlock Deepens on Capitol Hill

April 25, 2013

Includes 8-page Business & Regulatory Report.

April 11, 2003